Intellectual Property RightsIntellectual Property Rights – Recent Updates

July 8, 20150

A. IPAB Directs Patent Office to Grants Patent to CSIR’s Iodising Agent

Intellectual Property Appellate Board (IPAB) has directed the Patent Office to grant a patent to the national R&D organisation Council of Scientific & Industrial Research (CSIR) for a novel iodising agent finding its use in iodised salt.

B.IPAB Allows Abbott Biotech to File Appeal Against Cancellation of Patent for Humira Drug

Intellectual Property Appellate Board (IPAB) has allowed US pharma major Abbott Biotechnology to file an appeal against the order that cancelled the patent for its Humira drug

C.HUL and Gillette Agrees to Settle Trademark Dispute Amicably

Hindustan Unilever Ltd (HUL) and Gillette Company have entered into a settlement over the registration of Gillette’s application for a trademark, 7 O’ Clock, under a particular classification

Leave a Reply

Your email address will not be published. Required fields are marked *

Current day month ye@r *

© 2020-21 AMLEGALS Law Firm in Ahmedabad, Mumbai, Kolkata, New Delhi, Bengaluru for IBC, GST, Arbitration, Contract, Due Diligence, Corporate Laws, IPR, White Collar Crime, Litigation & Startup Advisory, Legal Advisory.


Disclaimer & Confirmation As per the rules of the Bar Council of India, law firms are not permitted to solicit work and advertise. By clicking on the “I AGREE” button below, user acknowledges the following:
    • there has been no advertisements, personal communication, solicitation, invitation or inducement of any sort whatsoever from us or any of our members to solicit any work through this website;
    • user wishes to gain more information about AMLEGALS and its attorneys for his/her own information and use;
  • the information about us is provided to the user on his/her specific request and any information obtained or materials downloaded from this website is completely at their own volition and any transmission, receipt or use of this site does not create any lawyer-client relationship; and that
  • We are not responsible for any reliance that a user places on such information and shall not be liable for any loss or damage caused due to any inaccuracy in or exclusion of any information, or its interpretation thereof.
However, the user is advised to confirm the veracity of the same from independent and expert sources.